Navigation Links
Cohen Milstein Sellers & Toll PLLC Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Orthofix International N.V.

NEW YORK, Jan. 20, 2016 /PRNewswire/ -- Cohen Milstein Sellers & Toll PLLC announces the preliminary approval of a proposed class action settlement that would benefit purchasers of common stock of Orthofix International N.V.



YOU ARE HEREBY NOTIFIED that a proposed Settlement has been reached in this Action. A hearing will be held with respect to the Settlement on April 28, 2016, at 4:30 P.M. before the Honorable John G. Koeltl, in the United States District Court for the Southern District of New York, Daniel Patrick Moynihan United States Courthouse, 500 Pearl St., Courtroom 12B, New York, New York 10007.

The purpose of the hearing is to determine whether the proposed Settlement of the securities class action claims asserted in this Action, pursuant to which Orthofix will cause to be deposited into a Settlement Fund the sum of eleven million U.S. dollars ($11,000,000.00) in exchange for the dismissal of the Action with prejudice and a release of claims against the Defendants and Released Parties, should be approved by the Court as fair, reasonable and adequate and in the best interests of the Class. If you purchased Orthofix common stock during the Class Period, you may be entitled to share in the distribution of the Settlement Fund if you submit a Proof of Claim Form postmarked no later than April 16, 2016 to the Claims Administrator at: Orthofix Securities Settlement, 600 N. Jackson St., Suite 3, Media, PA 19063, and if the information and documentation you provide in that Proof of Claim Form establishes that you are entitled to a recovery.

This Summary Notice provides only a summary of matters regarding the Action and the Settlement. A detailed notice (the "Notice") describing the Action, the proposed Settlement, and the rights of Class Members to appear in Court at the Final Approval Hearing, to request to be excluded from the Class, and/or to object to the Settlement, the Plan of Allocation and/or the request by Lead Counsel for an award of attorneys' fees and reimbursement of Litigation Expenses, has been mailed to persons or entities known to be potential Class Members. You may obtain a copy of that Notice, a Proof of Claim Form, the Settlement and other information at, or by writing to the following address or calling the following telephone number.

Orthofix Securities Settlement
c/o Strategic Claims Services
600 N. Jackson St.
Suite 3
Media, PA 19063
Tel: (866) 274-4004

If you are a Class Member, you have the right to object to the Settlement, the Plan of Allocation and/or the request by Lead Counsel for an award of attorneys' fees and Litigation Expenses, or otherwise request to be heard, by submitting no later than April 7, 2016, a written objection in accordance with the procedures described in the Notice. You also have the right to exclude yourself from the Class by submitting no later than April 7, 2016, a written request for exclusion from the Class in accordance with the procedures described in the Notice. If the Settlement is approved by the Court, you will be bound by the Settlement and the Court's Judgment, including the releases provided for in the Settlement and Judgment, unless you submit a request to be excluded.

PLEASE DO NOT CONTACT THE COURT OR THE CLERK'S OFFICE REGARDING THIS NOTICE. Inquiries, other than requests for the Notice, Proof of Claim Form and the Settlement referenced above, may be made to Lead Counsel for the Lead Plaintiff:

Daniel S. Sommers
1100 New York Ave N.W.
Suite 500, East Tower
Washington, D.C. 20005
Tel: (202) 408-4600

Dated: December 18, 2015

By Order of the Court,
United States District Court
for the Southern District of New York

SOURCE Cohen Milstein Sellers & Toll PLLC
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig
2. BioLife Solutions Appoints Raymond W. Cohen as Chairman and Joe Schick to Board of Directors
3. Cohen, Placitella & Roth, P.C. Reminds NECC Victims of January 15, 2014 Claim Filing Deadline to Participate in any Bankruptcy Court distributions
4. Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information
5. Cheryl Cohen, Former Medivation Chief Commercial Officer, Joins CytRx Board of Directors
6. Deceptive Practices By Illegal Online Drug Sellers Give Consumers a False Sense of Legitimacy and Safety, Reports NABP
7. RidgeCrest Herbals New Thyroid Thrive Joins Companys List Of Top 10 Bestsellers In Record Time
8. Sellers of Unapproved Drugs Proliferate Online, Posing a Serious Threat to Global Public Health, Reports NABP
9. Unilife Hires Intel Marketing Executive Kevin Sellers as Senior Vice President of Marketing and Communications
10. Electric Wheelchair Sellers Agree To $7.5 Million Settlement Of Whistleblower Case Alleging That Company Forged Medical Records As Part Of Scheme To Defraud Medicare
11. NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers
Post Your Comments:
(Date:10/8/2019)... ... October 08, 2019 , ... For many Americans, dental insurance is limited ... paid out of pocket. Yearly insurance payouts are generally capped at around $1,500—which doesn’t ... million people who are 65 or older. (Standard Medicare does not cover any dental ...
(Date:10/8/2019)... ... ... A free, interactive event highlighting innovations and ideas helping people with Parkinson’s live ... innovators and health experts, will display innovations that could help people with Parkinson’s disease ... on October 19 at the Coppertank Event Center in Austin, the event is co-hosted ...
(Date:10/8/2019)... ... 08, 2019 , ... Dr. Dorette Noorhasan offers a unique ... Fertility Doctor’s Fight for Motherhood (Brown Books Publishing Group), which releases today, October ... encourage, advise and support people who want to bring a new life into ...
Breaking Medicine Technology:
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... METAvivor Research ... breast cancer, announced the launch of its Stage IV Stampede campaign. The campaign will ... in Washington, DC that will include an advocacy boot camp, a march, a Die-In ...
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. ... has recently attended an advanced Level III training in Cagliari, Italy, this past ... training took place September 16-19, 2019 at the Sardinia Dental Teaching Center and ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... headquartered in Irving, Texas, that exclusively serves premier oral and maxillofacial surgeons – ... oral and maxillofacial surgery practice with two locations near Knoxville, Tennessee. The partnership ...
(Date:10/8/2019)... ... 08, 2019 , ... Continuing its leading research on human ... Care4U™ 2’-FL, a DuPont product, beneficially changes microbiota composition and the production of ... microbiota and metabolite composition by 2’-FL were between the responses elicited by GOS ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... is pleased to announce the addition of Brenda Thomas, an industry professional with ... Account Manager for the Professional Services Plans dental team at Brown & Brown ...
Breaking Medicine News(10 mins):